EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection

Majd Faraj, Karin Weissenborn, Bianca Teegen, Meike Dirks, Ann-Katrin Hennemann, Vanessa Wuttke, Winfried Stöcker, Nina Gödecke, Rainer Blasczyk, Anika Großhennig, Hannelore Ehrenreich, Gernot Beutel

Brain, Behavior, & Immunity - Health · 2026-11 · 57 · 101357

DOI: 10.1016/j.bbih.2026.101357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, & Immunity - Health, 2026-11. Verfasst von Majd Faraj und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover Medical School, Hannover, 30623, Germany. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various pathomechanisms are discussed as possible causes of Post-COVID syndrome (PCS). Immune system dysfunction with increase of autoimmune responses is one of them. Whether the observed increase of autoantibody prevalence after COVID-19 is of any significance for the well-being of affected subjects in the long-term is controversial. We assessed the seroprevalence of 44 autoantibodies against brain epitopes in 703 subjects a few months after a proven SARS-CoV-2 infection, and compared the results between 455 patients with Post-COVID syndrome and 248 subjects who had completely recovered. In addition, we looked for relationships between N-Methyl-D-Aspartate-Receptor-1 (NMDAR1)-autoantibody presence and symptoms during COVID-19 as well as Post-COVID symptoms in median 15.4 months after the infection, and we analyzed the occurrence of NMDAR1-autoantibodies regarding the severity of the PCS. We observed a slight increase in serum autoantibody prevalence in our cohort compared to published data for healthy controls from the pre-pandemic time. Interestingly, NMDAR1 autoantibodies were by far the most frequent, with an occurrence twice as much as reported in the pre-pandemic literature. The increase in occurrence was predominantly based on an increase of NMDAR1-IgM antibodies. We did not find differences in prevalence and features of auto-antibodies between patients with PCS and recovered individuals. Nor did we observe a relationship between the symptoms during COVID-19 or with PCS and the presence of serum autoantibodies. Our data further support the conjecture of a dysregulated immune system after COVID-19, and endorse former observations that there is no direct link between autoantibody prevalence and clinical symptoms of Post-COVID syndrome.

Schlagwörter

Stichwörter der Autor:innen

Brain binding autoantibodiesCOVID symptomsN-Methyl-D-Aspartat-Receptor-1 (NMDAR1)-autoantibodiesPost-COVID symptomsPost-COVID syndrome

Autor:innen und Institutionen

  • Department of Neurology, Hannover Medical School, Hannover, 30623, Germany.
  • Clinical Immunological Laboratory Prof. Dr. med. Winfried Stoecker, Gross Groenau near, Lübeck, Germany.
  • Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, 30623, Germany.
  • Institute for Biostatistics, Hannover Medical School, Hannover, 30623, Germany.
  • Georg-August University, Göttingen, Germany.
  • Academic Teaching Practice of Internal Medicine, Hannover Medical School, Hannover, Germany.

Zitieren

APA

Faraj, M., Weissenborn, K., Teegen, B., Dirks, M., Hennemann, A. K., Wuttke, V., Stöcker, W., Gödecke, N., Blasczyk, R., Großhennig, A., Ehrenreich, H., & Beutel, G. (2026). Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection. Brain, Behavior, & Immunity - Health, 57, 101357. https://doi.org/10.1016/j.bbih.2026.101357

Vancouver

Faraj M, Weissenborn K, Teegen B, Dirks M, Hennemann AK, Wuttke V, et al. Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection. Brain, Behavior, & Immunity - Health. 2026;57:101357. doi:10.1016/j.bbih.2026.101357

BibTeX
@article{Faraj2026,
  author = {Faraj, Majd and Weissenborn, Karin and Teegen, Bianca and Dirks, Meike and Hennemann, Ann-Katrin and Wuttke, Vanessa and Stöcker, Winfried and Gödecke, Nina and Blasczyk, Rainer and Großhennig, Anika and Ehrenreich, Hannelore and Beutel, Gernot},
  title = {Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection},
  journal = {Brain, Behavior, & Immunity - Health},
  year = {2026},
  volume = {57},
  pages = {101357},
  doi = {10.1016/j.bbih.2026.101357}
}
Kostenlos starten →